Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation

G. Gahrton, S. Tura, M. Flesch, A. Gratwohl, P. Gravett, G. Lucarelli, M. Michallet, J. Reiffers, O. Ringdén, M. T. van Lint

Research output: Contribution to journalArticle

Abstract

Of 14 patients who received an allogeneic bone marrow graft from HLA-compatible sibling donors, 10 have survived for 6 to 34 months posttransplantation (median, 12 months). Four patients have died, two of relapse at extramedullary sites, one of severe acute GVHD, and one from GI bleeding and pericardial effusion. One patient is alive in relapse and four patients have signs of minimal persistent disease. Five patients are well without signs of active disease. Minor improvement in osteolytic lesions on X-ray were seen in three patients, but the X-ray bone structure was mainly unchanged in most patients. Bone marrow transplantation appears promising for treatment of certain patients with multiple myeloma.

Original languageEnglish
Pages (from-to)1262-1264
Number of pages3
JournalBlood
Volume69
Issue number4
Publication statusPublished - 1987

Fingerprint

Multiple Myeloma
Bone Marrow Transplantation
Bone
X rays
Grafts
X-Rays
Recurrence
Pericardial Effusion
Siblings
Bone Marrow
Tissue Donors
Hemorrhage
Transplants
Bone and Bones

ASJC Scopus subject areas

  • Hematology

Cite this

Gahrton, G., Tura, S., Flesch, M., Gratwohl, A., Gravett, P., Lucarelli, G., ... van Lint, M. T. (1987). Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation. Blood, 69(4), 1262-1264.

Bone marrow transplantation in multiple myeloma : Report from the European Cooperative Group for Bone Marrow Transplantation. / Gahrton, G.; Tura, S.; Flesch, M.; Gratwohl, A.; Gravett, P.; Lucarelli, G.; Michallet, M.; Reiffers, J.; Ringdén, O.; van Lint, M. T.

In: Blood, Vol. 69, No. 4, 1987, p. 1262-1264.

Research output: Contribution to journalArticle

Gahrton, G, Tura, S, Flesch, M, Gratwohl, A, Gravett, P, Lucarelli, G, Michallet, M, Reiffers, J, Ringdén, O & van Lint, MT 1987, 'Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation', Blood, vol. 69, no. 4, pp. 1262-1264.
Gahrton G, Tura S, Flesch M, Gratwohl A, Gravett P, Lucarelli G et al. Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation. Blood. 1987;69(4):1262-1264.
Gahrton, G. ; Tura, S. ; Flesch, M. ; Gratwohl, A. ; Gravett, P. ; Lucarelli, G. ; Michallet, M. ; Reiffers, J. ; Ringdén, O. ; van Lint, M. T. / Bone marrow transplantation in multiple myeloma : Report from the European Cooperative Group for Bone Marrow Transplantation. In: Blood. 1987 ; Vol. 69, No. 4. pp. 1262-1264.
@article{690bbcf953db46efb42e430433ad3aa9,
title = "Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation",
abstract = "Of 14 patients who received an allogeneic bone marrow graft from HLA-compatible sibling donors, 10 have survived for 6 to 34 months posttransplantation (median, 12 months). Four patients have died, two of relapse at extramedullary sites, one of severe acute GVHD, and one from GI bleeding and pericardial effusion. One patient is alive in relapse and four patients have signs of minimal persistent disease. Five patients are well without signs of active disease. Minor improvement in osteolytic lesions on X-ray were seen in three patients, but the X-ray bone structure was mainly unchanged in most patients. Bone marrow transplantation appears promising for treatment of certain patients with multiple myeloma.",
author = "G. Gahrton and S. Tura and M. Flesch and A. Gratwohl and P. Gravett and G. Lucarelli and M. Michallet and J. Reiffers and O. Ringd{\'e}n and {van Lint}, {M. T.}",
year = "1987",
language = "English",
volume = "69",
pages = "1262--1264",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4",

}

TY - JOUR

T1 - Bone marrow transplantation in multiple myeloma

T2 - Report from the European Cooperative Group for Bone Marrow Transplantation

AU - Gahrton, G.

AU - Tura, S.

AU - Flesch, M.

AU - Gratwohl, A.

AU - Gravett, P.

AU - Lucarelli, G.

AU - Michallet, M.

AU - Reiffers, J.

AU - Ringdén, O.

AU - van Lint, M. T.

PY - 1987

Y1 - 1987

N2 - Of 14 patients who received an allogeneic bone marrow graft from HLA-compatible sibling donors, 10 have survived for 6 to 34 months posttransplantation (median, 12 months). Four patients have died, two of relapse at extramedullary sites, one of severe acute GVHD, and one from GI bleeding and pericardial effusion. One patient is alive in relapse and four patients have signs of minimal persistent disease. Five patients are well without signs of active disease. Minor improvement in osteolytic lesions on X-ray were seen in three patients, but the X-ray bone structure was mainly unchanged in most patients. Bone marrow transplantation appears promising for treatment of certain patients with multiple myeloma.

AB - Of 14 patients who received an allogeneic bone marrow graft from HLA-compatible sibling donors, 10 have survived for 6 to 34 months posttransplantation (median, 12 months). Four patients have died, two of relapse at extramedullary sites, one of severe acute GVHD, and one from GI bleeding and pericardial effusion. One patient is alive in relapse and four patients have signs of minimal persistent disease. Five patients are well without signs of active disease. Minor improvement in osteolytic lesions on X-ray were seen in three patients, but the X-ray bone structure was mainly unchanged in most patients. Bone marrow transplantation appears promising for treatment of certain patients with multiple myeloma.

UR - http://www.scopus.com/inward/record.url?scp=0023216770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023216770&partnerID=8YFLogxK

M3 - Article

C2 - 3548846

AN - SCOPUS:0023216770

VL - 69

SP - 1262

EP - 1264

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4

ER -